Remove Communication Remove Presentation Remove Vaccines
article thumbnail

Crisis Communications and FDA

Eye on FDA

In the face of a crisis situation, it is a given that the clarity and thoroughness of the communications response is key to resolving the issue and mitigating any reputational damage. When providing crisis counsel, there are some key things that I always think need to be accomplished in the communications around the situation.

article thumbnail

STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more

STAT

A little communication can go a long way.  The discordant trial results, presented on Oct. The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as Allegra, Dulcolax, and IcyHot.

Vaccines 279
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Temperature-stable tuberculosis vaccine induces immune response

European Pharmaceutical Review

The first clinical trial of any subunit tuberculosis (TB) vaccine in a temperature-stable form has found that ID93+GLA-SE, a freeze-dried vaccine, was safe. The recombinant subunit vaccine is made from four proteins of Mycobacterium tuberculosis bacteria combined with GLA-SE, an immune-stimulating adjuvant.

article thumbnail

IIL develops needle-free intranasal COVID-19 booster vaccine

Express Pharma

Indian Immunologicals Limited (IIL) has announced the development of a live-attenuated, needle-free intranasal booster vaccine against SARS-CoV-2. The vaccine was created using codon deoptimization technology in collaboration with Griffith University, Australia. The danger due to COVID-19 is still not over.

Vaccines 104
article thumbnail

As the Prospect of a Vaccine Approaches, Business and Communications Challenges Are Just Around the Corner

Eye on FDA

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. While vaccination may actually begin in December, the number of doses will be limited. In addition, the process of vaccination takes time.

article thumbnail

Pharma needs to adapt its communications or be left behind

pharmaphorum

Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Creating a more informed patient can improve outcomes and ultimately, quality of life.

article thumbnail

Impact of SARS-CoV-2 Subvariants on Vaccination

Pharmacy Times

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.